-
Bridge Biotherapeutics readies third IPO try after clinching mega dealIndustryAug 1, 2019‘No research, development only’ company proves potential through W1.5tr license-out deal with Boehringer Ingelheim -
Avellino Labs aims to set example for Kosdaq listing of US firmsIndustryJun 30, 2019From assisting disease prevention with DNA diagnosis, company aims for potentially curing genetic diseases
MOST POPULAR
-
01With historic Golden Boot, Son Heung-min cements case as greatest S. Korean footballer ever
-
Yoon congratulates Son Heung-min on becoming 1st Asian scoring champion in Premier League history02
-
03Chinese leverage in election sparks debate on foreigner suffrage
-
S. Korea's new COVID-19 cases hit 17-week low as omicron wave recedes04
-
05Korea to build reciprocal supply chain for chips, batteries in Indo-Pacific
-
Samsung seeks foundry supremacy with 3nm chips06
-
07[Newsmaker] Is Son the best footballer S. Korea has ever produced?
-
PM vows national unity, pledges swift implementation of extra budget08
-
09Samsung unveils largest-ever W450tr investment for chip supremacy
-
N. Korea's total suspected COVID-19 cases reach nearly 3 million: state media10